Shield Therapeutics is led by Anders Lundstrom, who serves as the Chief Executive Officer, guiding the commercial-stage pharmaceutical enterprise through its international expansion and market penetration strategies. Bringing extensive global healthcare and pharmaceutical leadership experience, he oversees the commercialization and distribution of the company's flagship iron deficiency treatments across major healthcare markets, optimizing operational performance and forging strategic commercial partnerships.